PT2874604T - Utilização de um agente quelante anfótero para a prevenção das alergias de contacto - Google Patents

Utilização de um agente quelante anfótero para a prevenção das alergias de contacto

Info

Publication number
PT2874604T
PT2874604T PT137474524T PT13747452T PT2874604T PT 2874604 T PT2874604 T PT 2874604T PT 137474524 T PT137474524 T PT 137474524T PT 13747452 T PT13747452 T PT 13747452T PT 2874604 T PT2874604 T PT 2874604T
Authority
PT
Portugal
Prior art keywords
chelating agent
preventing contact
contact allergies
amphoteric chelating
amphoteric
Prior art date
Application number
PT137474524T
Other languages
English (en)
Inventor
Meyer Marie-Claude
Blomet Joel
Mathieu Laurence
Original Assignee
Prevor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevor Int filed Critical Prevor Int
Publication of PT2874604T publication Critical patent/PT2874604T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT137474524T 2012-07-18 2013-07-17 Utilização de um agente quelante anfótero para a prevenção das alergias de contacto PT2874604T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1256939A FR2993466B1 (fr) 2012-07-18 2012-07-18 Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau

Publications (1)

Publication Number Publication Date
PT2874604T true PT2874604T (pt) 2018-05-11

Family

ID=47137836

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137474524T PT2874604T (pt) 2012-07-18 2013-07-17 Utilização de um agente quelante anfótero para a prevenção das alergias de contacto

Country Status (18)

Country Link
US (3) US10953024B2 (pt)
EP (2) EP2874604B1 (pt)
CN (4) CN104507501A (pt)
AU (2) AU2013291792B2 (pt)
BR (2) BR112015001018B1 (pt)
CA (2) CA2878882C (pt)
DK (2) DK2874604T3 (pt)
ES (2) ES2690060T3 (pt)
FR (1) FR2993466B1 (pt)
IN (1) IN2014DN10924A (pt)
MX (2) MX359747B (pt)
NO (1) NO2874604T3 (pt)
NZ (2) NZ703409A (pt)
PL (2) PL2874604T3 (pt)
PT (1) PT2874604T (pt)
SI (1) SI2874661T1 (pt)
TR (1) TR201815143T4 (pt)
WO (2) WO2014013194A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3093001B1 (fr) * 2019-02-22 2022-06-10 Prevor Int Composition pour enlever des residus chimiques et ses utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604900B1 (fr) * 1986-10-08 1989-01-13 Blomet Marie Claude Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5587400A (en) * 1993-04-19 1996-12-24 Marie-Claude Blomet epouse Meyer Physiological composition for the treatment of thermal or chemical burns
US5665804A (en) * 1996-02-05 1997-09-09 Dow Corning Corporation Silicone latex solvent thickening
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6242042B1 (en) * 1998-09-14 2001-06-05 Lrc Products Ltd. Aqueous coating composition and method
US6582683B2 (en) * 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
FR2809959B1 (fr) * 2000-06-07 2004-10-29 Marie Claude Meyer Utilisation d'un complexe d'aluminium et de ligand ethylenediamine-tetraacetique pour la prevention et/ou le traitement des urticaires
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
GB0324084D0 (en) * 2003-10-14 2003-11-19 Oxagen Ltd Compounds
RU2006109108A (ru) * 2003-10-14 2007-11-20 Оксаген Лимитед (GB) Соединения, обладающие активностью антагонистов crth2 рецепторов
US20090019224A1 (en) * 2005-02-02 2009-01-15 Pocrass Alan L Data Storage and Transfer Device and Method
MY161558A (en) * 2008-01-18 2017-04-28 Vystar Corp Natural rubber latex having reduced allergenicity and method of making
WO2011041680A2 (en) * 2009-10-02 2011-04-07 The Brigham And Women's Hospital, Inc. Compositions and methods of prophylaxis for contact dermatitis

Also Published As

Publication number Publication date
MX2015000785A (es) 2015-09-16
CA2878882A1 (fr) 2014-01-23
US10953024B2 (en) 2021-03-23
CN110179686A (zh) 2019-08-30
CN104470501A (zh) 2015-03-25
NZ703258A (en) 2016-11-25
US11197874B2 (en) 2021-12-14
DK2874661T3 (en) 2018-11-05
US20150190357A1 (en) 2015-07-09
BR112015001018A2 (pt) 2017-06-27
WO2014013195A1 (fr) 2014-01-23
ES2690060T3 (es) 2018-11-19
IN2014DN10924A (pt) 2015-09-18
FR2993466A1 (fr) 2014-01-24
FR2993466B1 (fr) 2014-08-15
BR112015001019A2 (pt) 2017-06-27
WO2014013194A1 (fr) 2014-01-23
CN108606964A (zh) 2018-10-02
DK2874604T3 (en) 2018-05-22
AU2013291792B2 (en) 2017-11-09
EP2874661A1 (fr) 2015-05-27
PL2874661T3 (pl) 2018-12-31
US20210275553A1 (en) 2021-09-09
EP2874604B1 (fr) 2018-02-14
EP2874661B1 (fr) 2018-08-08
CA2878882C (fr) 2020-08-18
MX2015000786A (es) 2015-09-16
CA2878650C (fr) 2020-07-21
PL2874604T3 (pl) 2018-07-31
EP2874604A1 (fr) 2015-05-27
MX356811B (es) 2018-06-13
AU2013291792A1 (en) 2015-01-22
TR201815143T4 (tr) 2018-11-21
CN104507501A (zh) 2015-04-08
MX359747B (es) 2018-10-08
CA2878650A1 (fr) 2014-01-23
AU2013291793A1 (en) 2015-01-22
BR112015001019B1 (pt) 2022-07-19
SI2874661T1 (sl) 2018-11-30
NO2874604T3 (pt) 2018-07-14
ES2667709T3 (es) 2018-05-14
US20150202217A1 (en) 2015-07-23
NZ703409A (en) 2016-11-25
AU2013291793B2 (en) 2017-11-23
BR112015001018B1 (pt) 2021-09-08

Similar Documents

Publication Publication Date Title
PL2992093T3 (pl) Środek czyszczący zawierający proteazy
AP4029A (en) Inhibitors of beta-secretase
IL233596A0 (en) A method to prevent allergies
HK1214269A1 (zh) 肌萎縮側索硬化症 治療
EP2823830A4 (en) MESH-HIGHNESS MEDIUM
HK1206620A1 (en) Therapeutic agent for dyslipidemia
HK1211947A1 (en) Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors
EP2940497A4 (en) POLARIZING MASK
HK1201252A1 (en) Modified blasting agent
HUE051648T2 (hu) CCR3-gátlók használata
EP2937099A4 (en) APOPOTOSIS INDUCING AGENT
HK1206976A1 (en) Composition for agent for external use
IL236963A0 (en) beta-secretase inhibitors
HK1214152A1 (zh) 用於肌萎縮性側索硬化的治療劑
HK1207311A1 (en) Agent for ameliorating allergy
EP2919816A4 (en) COMBINATION TREATMENT FOR AMYOTROPHE LATERAL SCLEROSIS (ALS)
EP2814479A4 (en) METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
EP2811999A4 (en) NOVEL CYSTEINE PROTEASE INHIBITORS AND USES THEREOF
PL2874604T3 (pl) Stosowanie amfoterycznego środka chelatującego dla zapobiegania alergiom kontaktowym
GB201223029D0 (en) Chelating agents
GB201223030D0 (en) Chelating Agents
GB201208947D0 (en) Aspartic protease inhibitors